FDAnews Device Daily Bulletin
Medical Devices / Submissions and Approvals

FDA Clears Angiography Module for Spectralis Imaging Devices

Sept. 20, 2018

The FDA cleared Spectralis’ optical coherence tomography angiography (OCTA) module for use with its new and existing diagnostic imaging devices.

OCTA is a non-invasive imaging technique that produces 3D visualization of perfused ocular vasculature.

The module allows physicians to gain better insights into ocular abnormalities.

View today's stories